TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
22/04/2025
Voltar para busca
Dado oficial do USPTO
ECLIPSYS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
27/04/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
13/05/2022
Data de registro
03/10/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/10/2023
Última transação
27/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
11
Localização do titular
Zurich, CH
Examinador
BRACEY, KAREN
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Amphista Therapeutics Limited
Amphista Therapeutics Limited
Representantes
Rob LeBlanc Greenberg Traurig, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in science; chemical compositions and agents for use in science; chemical preparations for use in the manufacture of pharmaceutical drugs; biological preparations for use in science; chemicals for biotechnological manufacturing processes; diagnostic preparations used for scientific or research use; reagents used for scientific or research use; proteins in raw material form for scientific or research use; none of the aforesaid relating to reagents and chemicals for use in relation to biochemicals, oligonucleotides, oligonucleotide conjugates, DNA primers, DNA, genetic, and oligonucleotide probes, and quenchers
Classe 5
Pharmaceuticals, medicinal and veterinary preparations for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; diagnostic preparations for medical and veterinary use; medicines and biotechnological preparations for medical use for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; biological and chemical reagents for medical use; pharmaceutical drugs for medical purposes for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; none of the aforesaid goods being for the treatment and care of wounds and none of the aforesaid relating to reagents and chemicals for use in relation to biochemicals, oligonucleotides, oligonucleotide conjugates, DNA primers, DNA, genetic, and oligonucleotide probes, and quenchers
Classe 42
Scientific and technological services, namely, scientific analysis, testing, engineering, development, research, and design in the field of drug discovery and the identification and development of pharmaceutical and medicinal preparations; consultancy relating to product research and development in the field of pharmaceutical and medicinal preparations for therapeutic use; research and development in the field of medical diagnostics; biotechnological and chemical testing; research and development in the pharmaceutical, chemical and biotechnological fields; research and development in the field of medicinal preparations; drug discovery services; development of pharmaceutical preparations and medicines; pharmaceutical drug development services; none of the aforesaid relating to reagents and chemicals for use in relation to biochemicals, oligonucleotides, oligonucleotide conjugates, DNA primers, DNA, genetic, and oligonucleotide probes, and quenchers
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/04/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
22/04/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
22/04/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/10/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/07/2023
PUBO
PUBLISHED FOR OPPOSITION
18/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/03/2023
GNRT
NON-FINAL ACTION E-MAILED
03/03/2023
CNRT
NON-FINAL ACTION WRITTEN
03/03/2023
DOCK
ASSIGNED TO EXAMINER
02/03/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
15/02/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/02/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
15/02/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/02/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/02/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
14/02/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/02/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/02/2023
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
02/06/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
02/06/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/05/2022
NWAP
NEW APPLICATION ENTERED
17/05/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ECLIPSYS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.